Form 4: GeneDx Holdings CFO Kevin Feeley Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Kevin Feeley, CFO of GeneDx Holdings Corp., exercised stock options and sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan on April 9, 2025.
Summary
- On April 9, 2025, Kevin Feeley, the CFO of GeneDx Holdings Corp., exercised an employee stock option to acquire 1,246 shares of Class A Common Stock at a price of $32.67 per share.
- Simultaneously, Feeley sold a total of 15,462 shares of Class A Common Stock in multiple transactions at prices ranging from $83.6689 to $97.26 per share.
- These sales were executed under a Rule 10b5-1 trading plan adopted on August 21, 2024.
- Following these transactions, Feeley directly owns 1,726 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't convey any particular positive or negative sentiment about the company's performance or prospects.
Future Outlook
There is no future outlook provided in this document.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily reflect broader industry trends. However, it's common for executives to utilize 10b5-1 plans to manage their stock holdings and avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 08/21/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 04/09/2025 | Date of stock option exercise and share sales |
| 04/10/2025 | Date of Form 4 filing |
| 08/31/2032 | Expiration date of Employee Stock Option |
Keywords
Form 4, GeneDx Holdings Corp, Kevin Feeley, WGS, CFO, Stock Options, Share Sales, 10b5-1 Trading Plan, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.